July 25, 2017
Jurors in the securities fraud trial of Martin Shkreli on Tuesday heard from the last witness expected to be called in the case, and were shown a trove of emails showing the "pharma bro" berating his former Katten Muchin attorney and co-defendant as they discussed ways to pay off disgruntled investors.
July 24, 2017
Martin Shkreli on Monday told a New York federal judge that he will not take the witness stand in his own defense at his securities fraud trial, while jurors were shown documents indicating that Shkreli's hedge funds were strapped for cash while he boasted of hefty returns for investors.
July 21, 2017
The government's case against "pharma bro" Martin Shkreli inched toward conclusion on Friday, with both sides engaged in heated sparring over the final pieces of evidence and testimony in the closely watched securities fraud trial.
July 20, 2017
Attorneys for Martin Shkreli and prosecutors in his securities fraud trial on Thursday traded barbs over a government bid to admit a slew of investor documents into evidence without calling those investors to the witness stand, which the defense claims would violate Shkreli's Sixth Amendment rights.
July 19, 2017
A Brooklyn federal judge on Wednesday put the securities fraud trial of Martin Shkreli on hold after prosecutors sought to introduce a host of investor documents without calling those witnesses to testify, sounding skeptical about the government's tactic.
July 18, 2017
A former portfolio manager for one of Martin Shkreli's MSMB hedge funds on Tuesday told a Brooklyn federal jury of how the onetime pharmaceutical executive turned nasty when a dispute arose over the ownership of some Retrophin stock, with Shkreli telling the man's wife he wanted to make her and her children homeless.
July 17, 2017
An investor in Martin Shkreli-run hedge funds told the Brooklyn federal jury hearing securities fraud allegations against the pharma bad boy Monday that he saw his investment value plunge and was denied the promised opportunity to recoup his cash, but like others ended up in the black with the stock of drug company Retrophin Inc.
July 14, 2017
The CEO and board member of Retrophin Inc. on Friday confirmed to a Brooklyn jury he received messages early on regarding settlement agreements in which the company picked up the tab for former CEO Martin Shkreli's debt to investors, despite testifying earlier that the deals were never discussed or approved.
July 13, 2017
The CEO of Retrophin Inc. on Thursday told a jury at Martin Shkreli's federal fraud trial in Brooklyn, New York, that the "visionary" pharma bro was like the Pied Piper, getting him to stay on the company's board of directors despite his misgivings about Shkreli's bookkeeping and honesty.
July 12, 2017
The former chairman of Retrophin Inc. testified Wednesday in New York federal court that Martin Shkreli stunned him with a lie, threatened to replace him and, after Shkreli was canned as CEO, bragged he would start another company that would outperform his brainchild.